ClinConnect ClinConnect Logo
Search / Trial NCT03891251

Collecting Recorded Videos of Colonoscopy

Launched by MAGENTIQ EYE LTD · Mar 23, 2019

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on testing a new device called the APDS during colonoscopy procedures. Colonoscopies are tests used to look inside the colon and can help detect growths called polyps, which may lead to cancer. The main goal of the study is to see how well the APDS device works in finding these polyps, and to explore the possibilities of a newer version of the device in the future.

To participate in this study, individuals need to be at least 18 years old and able to read and understand the information provided about the trial. However, those with certain health issues, like bleeding disorders or serious illnesses, cannot participate. If eligible, participants can expect to undergo a standard colonoscopy with the added evaluation of the APDS device. The study is currently recruiting, and everyone, regardless of gender, is welcome to apply.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects must meet all the - criteria related to regular colonoscopy according to the standard of care at the Gastroenterology Department of the selected center, _In addition the following - criteria have to be met to be eligible for the study:
  • 1. Able to read, understand and provide written Informed Consent;
  • 2. Females or males - older than 18 years old
  • Exclusion Criteria:
  • Any of the following colonoscopy related exclusion criteria will exclude the subject from the study:
  • Bleeding disorder or unacceptable risk of bleeding
  • Terminal illness or life threatening malignancy

About Magentiq Eye Ltd

Magentiq Eye Ltd. is a pioneering clinical trial sponsor dedicated to advancing ocular health through innovative research and development. With a focus on harnessing cutting-edge technologies and methodologies, the company aims to improve treatment outcomes for patients with various eye conditions. By collaborating with leading experts and institutions, Magentiq Eye Ltd. is committed to conducting rigorous clinical trials that prioritize patient safety and efficacy, ultimately striving to bring transformative therapies to the ophthalmic market.

Locations

Jerusalem, , Israel

Patients applied

0 patients applied

Trial Officials

Harold Jacob, MD

Principal Investigator

Senior Gastroenterologist

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials